Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Stephen Basso | Chief Financial Officer | 2024-03-05 | 12,096 | $14.88 | $179.99kBuy |
Matthew Ronsheim | Officer | 2024-03-05 | 12,768 | $14.88 | $189.99kBuy |
Marianne Zhen | Chief Accounting Officer | 2024-03-05 | 10,752 | $14.88 | $159.99kBuy |
Marianne Zhen | Chief Accounting Officer | 2024-02-20 | 2,862 | $15.80 | $45.22kSell |
Matthew Ronsheim | Officer | 2024-02-20 | 807 | $15.80 | $12.75kSell |
Matthew Ronsheim | Officer | 2024-01-18 | 1,600 | $16.05 | $25.68kSell |
Marianne Zhen | Chief Accounting Officer | 2023-11-20 | 784 | $13.62 | $10.68kSell |
Marianne Zhen | Chief Accounting Officer | 2023-11-15 | 5,589 | $14.01 | $78.30kSell |
Marianne Zhen | Chief Accounting Officer | 2023-11-15 | 5,405 | $13.97 | $75.51kSell |
Marianne Zhen | Chief Accounting Officer | 2023-08-18 | 785 | $13.64 | $10.71kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Glaxosmithkline PLC | 50.62% | 32,005,260 | $463.12M | Insider |
Blackrock Inc | 16.37% | 10,352,073 | $149.79M | Institution |
Alexander J. Denner | 11.51% | 7,277,000 | $105.30M | Insider |
Sarissa Capital Management LP | 11.51% | 7,277,000 | $105.30M | Institution |
Vanguard Group Inc | 10.62% | 6,712,443 | $97.13M | Institution |
Putnam Investments LLC | 9.92% | 6,270,413 | $90.73M | Institution |
Dimensional Fund Advisors LP | 7.14% | 4,516,999 | $65.36M | Institution |
Renaissance Technologies LLC | 6.55% | 4,144,447 | $59.97M | Institution |
Jeffrey M. Drazan | 4.58% | 2,893,921 | $41.88M | Insider |
Westfield Capital Management Co LP | 4.13% | 2,614,127 | $37.83M | Institution |